Difluprednate clinical trials
Also written Durezol.
How each study uses difluprednate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 23 Jun 2008 · DUREZOL · NDA 022212 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2018 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 15 · Other 3
Sirion Therapeutics, Inc. (11) · Alcon Research (3) · Laboratorios Sophia S.A de C.V. (1) · Edward J. Holland (1) · University of California, San Francisco (1) · Kafrelsheikh University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Corticosteroids source
Studies
Open first, then newest update. How each study uses difluprednate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 18
- A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After PhacoemulsificationStatus unknownPhase 4Kafrelsheikh UniversityNCT05649111Written as Difluprednate Eye DropsHow we know
- Macular Edema Nepafenac vs. Difluprednate Uveitis TrialTerminatedPhase 4University of California, San FranciscoNCT01939691Written as DifluprednateHow we know
- Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After PhacoemulsificationCompletedPhase 3Laboratorios Sophia S.A de C.V.NCT03693989Written as Difluprednate 0.05%How we know
- Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract SurgeryCompletedPhase 3Alcon ResearchNCT01124045Written as Difluprednate ophthalmic emulsion, 0.05%How we know
- Evaluation of Anti-Inflammatory Treatment in Dry Eye PatientsCompletedPhase 2Alcon ResearchNCT01276223Written as Difluprednate 0.05% ophthalmic emulsionHow we know
- Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior UveitisCompletedPhase 3Alcon ResearchNCT01201798Written as Difluprednate 0.05% ophthalmic emulsionHow we know
- Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.CompletedPhase 4Edward J. HollandNCT01244334Written as Difluprednate ophthalmic emulsion 0.05%How we know
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)CompletedPhase 3Sirion Therapeutics, Inc.NCT00616993Written as DifluprednateHow we know
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)CompletedPhase 3Sirion Therapeutics, Inc.NCT00616070Written as DifluprednateHow we know
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)CompletedPhase 3Sirion Therapeutics, Inc.NCT00430092Written as DifluprednateHow we know
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)CompletedPhase 3Sirion Therapeutics, Inc.NCT00429923Written as DifluprednateHow we know
- Study of Difluprednate in the Treatment of UveitisCompletedPhase 3Sirion Therapeutics, Inc.NCT00501579Written as DifluprednateHow we know
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative InflammationCompletedPhase 2Sirion Therapeutics, Inc.NCT00407225Written as Difluprednate Ophthalmic EmulsionHow we know
- Study of Difluprednate Ophthalmic Emulsion in Postoperative InflammationCompletedPhase 3Sirion Therapeutics, Inc.NCT00406341Written as Difluprednate Ophthalmic EmulsionHow we know
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe UveitisCompletedPhase 3Sirion Therapeutics, Inc.NCT00407056Written as Difluprednate Ophthalmic EmulsionHow we know
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative InflammationCompletedPhase 2Sirion Therapeutics, Inc.NCT00406497Written as Difluprednate Ophthalmic EmulsionHow we know
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of UveitisCompletedPhase 3Sirion Therapeutics, Inc.NCT00406887Written as Difluprednate Ophthalmic EmulsionHow we know
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of UveitisCompletedPhase 2Sirion Therapeutics, Inc.NCT00405496Written as Difluprednate Ophthalmic EmulsionHow we know
As the comparator · 1 — what is tested is compared with difluprednate
Codes
What other systems call difluprednate · ClinicalTrials.gg INT002635
- MeSH (NLM) C015808difluprednateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S8A06QG2QEDIFLUPREDNATEConfirmed FDA, NLM, Wikidata
- RxNorm 23043Confirmed FDA, Wikidata
- Wikidata Q736113difluprednateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C80259DifluprednateOne source FDA
- DrugBank DB06781One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C015808 | difluprednate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S8A06QG2QE | DIFLUPREDNATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 23043 | — | Confirmed FDA, Wikidata |
| Wikidata | Q736113 | difluprednate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C80259 | Difluprednate | One source FDA |
| DrugBank | DB06781 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.